Synthetic cannabinoid use in a nationally representative sample of US high school seniors

Drug and Alcohol Dependence

Volumn 149, Issue , 2015, Pages 194-202

  Palamar, Joseph J ^a,b   Acosta, Patricia ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

Adolescents; Marijuana; Sociodemographics; Synthetic cannabinoids

Indexed keywords

CANNABINOID; CANNABIS; ILLICIT DRUG; STREET DRUG;

ADOLESCENT; ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLACK PERSON; DRUG USE; FEMALE; HIGH SCHOOL STUDENT; HUMAN; MALE; PRIORITY JOURNAL; RELIGION; SMOKING; UNITED STATES; CANNABIS SMOKING; PREVALENCE; RISK FACTOR; STUDENT; SUBSTANCE-RELATED DISORDERS; SYNTHESIS; YOUNG ADULT;

CANNABIS; CANNABIS SATIVA;

ADOLESCENT; CANNABINOIDS; FEMALE; HUMANS; MALE; MARIJUANA SMOKING; PREVALENCE; RISK FACTORS; STREET DRUGS; STUDENTS; SUBSTANCE-RELATED DISORDERS; UNITED STATES; YOUNG ADULT;

EID: 84926209721     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2015.01.044     Document Type: Article

References (44)

1. American Association of Poison Control Centers Synthetic Cannabinoid Data 2014, 〈http://www.aapcc.org/alerts/synthetic-marijuana〉 (accessed 03.01.15).
2. Barratt M.J., Cakic V., Lenton S. Patterns of synthetic cannabinoid use in Australia. Drug Alcohol Rev. 2013, 32:141-146.
3. Bernson-Leung M.E., Leung L.Y., Kumar S. Synthetic cannabis and acute ischemic stroke. J Stroke Cerebrovasc. 2013, 23:1239-1241.
4. Bruno R., Matthews A.J., Dunn M., Alati R., McIlwraith F., Hickey S., Burns L., Sindicich N. Emerging psychoactive substance use among regular ecstasy users in Australia. Drug Alcohol Depend. 2012, 124:19-25.
5. Castaneto M.S., Gorelick D.A., Desrosiers N.A., Hartman R.L., Pirard S., Huestis M.A. Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug Alcohol Depend. 2014, 144C:12-41.
6. Caviness C.M., Tzilos G., Anderson B.J., Stein M.D. Synthetic cannabinoids: use and predictors in a community sample of young adults. Subst. Abuse 2014, 15. [Epub ahead of print].
7. Centers for Disease Control and Prevention Notes from the field: severe illness associated with synthetic cannabinoid use-Brunswick, Georgia, 2013. Morb. Mortal. Wkly. Rep. 2013, 62:939.
8. Centers for Disease Control and Prevention Acute kidney injury associated with synthetic cannabinoid use-multiple states, 2012. Morb. Mortal. Wkly. Rep. 2013, 62:93-98.
9. Community Epidemiology Work Group Epidemiologic Trends in Drug Abuse: Proceedings of the Community Epidemiology Work Group 2013, National Institute on Drug Abuse, 〈http://www.drugabuse.gov/sites/default/files/files/cewg_january_2013_vol1_508.pdf〉 (accessed 28.10.14).
10. Degenhardt L., Chiu W.T., Sampson N., Kessler R.C., Anthony J.C. Epidemiological patterns of extra-medical drug use in the United States: evidence from the national comorbidity survey replication, 2001-2003. Drug Alcohol Depend. 2007, 90:210-223.
11. Department of Justice, Drug Enforcement Administration Schedules of controlled substances: temporary placement of four synthetic cannabinoids into Schedule I. 21 CFR Part 1308 [Docket No. DEA-385]. Fed. Regist. 2014, 79:7577-7582.
12. European Monitoring Centre for Drugs and Drug Addiction EU Drug Markets Report: A Strategic Analysis 2013, 〈http://www.emcdda.europa.eu/publications/joint-publications/drug-markets〉 (accessed 28.10.14).
13. Forrester M.B., Kleinschmidt K., Schwarz E., Young A. Synthetic cannabinoid and marijuana exposures reported to poison centers. Hum. Exp. Toxicol. 2012, 3:1006-1011.
14. Gunderson E.W., Haughey H.M., Ait-Daoud N., Joshi A.S., Hart C.L. A survey of synthetic cannabinoid consumption by current cannabis users. Subst. Abuse 2014, 35:184-189.
15. Heeringa S.G., West B.T., Berglund P.A. Applied Survey Data Analysis 2010, Chapman and Hall, London.
16. Hoyte C.O., Jacob J., Monte A.A., Al-Jumaan M., Bronstein A.C., Heard K.J. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. Ann. Emerg. Med. 2012, 60:435-438.
17. Hu X., Primack B.A., Barnett T.E., Cook R.L. College students and use of K2: an emerging drug of abuse in young persons. Subst. Abuse Treat. Prev. Policy 2011, 11:6-16.
18. Hurst D., Loeffler G., McLay R. Psychosis associated with synthetic cannabinoid agonists: a case series. Am. J. Psychiatry 2011, 168:1119.
19. Johnston L.D., O'Malley P.M., Bachman J.G., Schulenberg J.E., Miech R.A. Monitoring the Future National Survey Results on Drug Use, 1975-2013: Volume I, Secondary School Students 2014, 〈http://www.monitoringthefuture.org/pubs/monographs/mtf-vol1_2013.pdf〉 (accessed 28.10.14).
20. Johnston L.D., O'Malley P.M., Bachman J.G., Schulenberg J.E., Miech R.A. Demographic subgroup trends among adolescents in the use of various licit and illicit drugs, 1975-2013. Monitoring the Future Occasional Paper 81 2014, Institute for Social Research, Ann Arbor, MI, 〈http://www.monitoringthefuture.org/pubs/occpapers/mtf-occ81.pdf〉 (accessed 30.12.14).
21. Johnston L.D., O'Malley P.M., Miech R.A., Bachman J.G., Schulenberg J.E. Monitoring the Future National Survey Results on Drug Use: 1975-2014: Overview. Key Findings on Adolescent Drug Use 2015, Institute for Social Research, The University of Michigan, Ann Arbor.
22. Kronstrand R., Roman M., Andersson M., Eklund A. Toxicological findings of synthetic cannabinoids in recreational users. J. Anal. Toxicol. 2013, 37:534-541.
23. McElrath K., O'Neill C. Experiences with mephedrone pre- and post-legislative controls: perceptions of safety and sources of supply. Int. J. Drug Policy 2011, 22:120-127.
24. Mir A., Obafemi A., Young A., Kane C. Myocardial infarction associated with use of the synthetic cannabinoid K2. Pediatrics 2011, 128:1622-1627.
25. Moore K., Dargan P.I., Wood D.M., Measham F. Do novel psychoactive substances displace established club drugs, supplement them or act as drugs of initiation? The relationship between mephedrone, ecstasy and cocaine. Eur. Addict. Res. 2013, 19:276-282.
26. Nacca N., Vatti D., Sullivan R., Sud P., Su M., Marraffa J. The synthetic cannabinoid withdrawal syndrome. J. Addict. Med. 2013, 7:296-298.
27. New York City Department of Health and Mental Hygiene (NYC DHMH) Health Department Warns New Yorkers of Dangers of Synthetic Cannabinoids. Press Release # 023-14 2014, 〈http://www.nyc.gov/html/doh/html/pr2014/pr023-14.shtml〉 (accessed 27.07.14).
28. Palamar J.J., Kamboukos D. An examination of sociodemographic correlates of ecstasy use among high school seniors in the United States. Subst. Use Misuse 2014, 49:1774-1783.
29. Palamar J.J., Ompad D.C. Demographic and socioeconomic correlates of powder cocaine and crack use among high school seniors in the United States. Am. J. Drug Alcohol Abuse 2014, 40:37-43.
30. Palamar J.J., Ompad D.C., Petkova E. Correlates of intentions to use cannabis among US high school seniors in the case of cannabis legalization. Int. J. Drug Policy 2014, 25:424-435.
31. Palamar J.J., Zhou S., Sherman S., Weitzman M. Hookah use among US high school seniors. Pediatrics 2014, 134:227-234.
32. Pew Research Center Majority Now Supports Legalizing Cannabis 2013, 〈http://www.people-press.org/files/legacy-pdf/4-4-13%20Cannabis%20Release.pdf〉 (accessed 28.10.14).
33. Rao J.N.K., Scott A.J. On chi-squared tests for multi-way tables with cell proportions estimated from survey data. Ann. Stat. 1984, 12:46-60.
34. Rogers S. Which drugs do you take? US and the UK compared by the Global Drug Survey. The Guardian 2012, 〈http://www.theguardian.com/society/datablog/2012/mar/15/global-drug-survey-us-uk#data〉 (accessed 28.10.14).
35. ® 9.3 2011, SAS Institute, Cary, NC.
36. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality The DAWN Report: Highlights of the 2011 Drug Abuse Warning Network (DAWN) Findings on Drug-related Emergency Department Visits 2013, 〈http://www.samhsa.gov/data/sites/default/files/DAWN127/DAWN127/sr127-DAWN-highlights.htm〉 (accessed 28.10.14).
37. Terry-McElrath Y.M., O'Malley P.M., Johnston L.D. Simultaneous alcohol and marijuana use among U.S. high school seniors from 1976 to 2011: trends, reasons, and situations. Drug Alcohol Depend. 2013, 133:71-79.
38. Van Hout M.C., Brennan R. Heads held high: an exploratory study of legal highs in pre-legislation Ireland. J. Ethn. Subst. Abuse 2011, 10:256-272.
39. Vandrey R., Dunn K.E., Fry J.A., Girling E.R. A survey study to characterize use of spice products (synthetic cannabinoids). Drug Alcohol Depend. 2012, 120:238-241.
40. Wallace J.M., Vaughn M.G., Bachman J.G., O'Malley P.M., Johnston L.D., Schulenberg J.E. Race/ethnicity, socioeconomic factors, and smoking among early adolescent girls in the United States. Drug Alcohol Depend. 2009, 104:S42-S49.
41. Wiley J.L., Marusich J.A., Huffman J.W. Moving around the molecule: relationship between chemical structure and in vivo activity of synthetic cannabinoids. Life Sci. 2013, 23:531-534.
42. Winstock A.R., Barratt M.J. Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample. Drug Alcohol Depend. 2013, 131:106-111.
43. Winstock A.R., Barratt M.J. The 12-month prevalence and nature of adverse experiences resulting in emergency medical presentations associated with the use of synthetic cannabinoid products. Hum. Psychopharmacol. 2013, 28:390-393.
44. Wood K.E. Exposure to bath salts and synthetic tetrahydrocannabinol from 2009 to 2012 in the United States. J. Pediatr. 2013, 163:213-216.